HCPCS Level IIdrugActive
J7514
Mycophenol (myhibbin) 100 mg
BETOS: O1E
Effective: 2025-01-01
Referenced in 1 policies
Description
Mycophenolate mofetil (myhibbin), oral suspension, 100 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Myhibbin
Manufacturer
Azurity Pharmaceuticals, Inc.
HCPCS Dosage
100 MG
Billing Units
350.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.